About
Laguna Bio develops engineered microbial immunotherapies that activate innate immune cells in vivo to target and eliminate cancer, using its proprietary QUAIL platform to create scalable, durable cancer treatments.
Explore Laguna Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.